Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

O. Akkerman · SciRah

Researcher profile · Semantic Scholar

O. Akkerman

Share profile

O. Akkerman — researcher profile on SciRah

h-index: 33
Works: 198
Citations: 4,598

Most-cited papers

Treatment of Highly Drug-Resistant Pulmonary Tuberculosis.
M. Bolhuis, T. V. van der Werf, O. Akkerman
2020New England Journal of Medicine285 citations Open access
Semantic Scholar
Worldwide Effects of Coronavirus Disease Pandemic on Tuberculosis Services, January–April 2020
G. Migliori, P. M. Thong, O. Akkerman, J. Alffenaar +52 more
2020Emerging Infectious Diseases188 citations Open access
Semantic Scholar
Clinical standards for the assessment, management and rehabilitation of post-TB lung disease.
G. Migliori, F. Marx, N. Ambrosino, E. Zampogna +55 more
2021The International Journal of Tuberculosis and Lung Disease182 citations Open access
Semantic Scholar
Clinical standards for the dosing and management of TB drugs
J. Alffenaar, S. Stocker, L. D. Forsman, A. Garcia-Prats +47 more
2022The International Journal of Tuberculosis and Lung Disease64 citations Open access
Semantic Scholar
Clinical and economic impact of medication non-adherence in drug-susceptible tuberculosis: a systematic review.
R. A. Chimeh, F. Gafar, I. S. Pradipta, O. Akkerman +3 more
2020The International Journal of Tuberculosis and Lung Disease60 citations Open access
Semantic Scholar
The pharmacokinetics of antibiotics in cystic fibrosis
A. M. Akkerman-Nijland, O. Akkerman, F. Grasmeijer, P. Hagedoorn +4 more
2020Expert Opinion on Drug Metabolism & Toxicology58 citations Open access
Semantic Scholar
Delamanid-containing regimens and multidrug-resistant tuberculosis: A systematic review and meta-analysis
M. Nasiri, M. Zangiabadian, Erfan Arabpour, S. Amini +21 more
2022International Journal of Infectious Diseases52 citations Open access
Semantic Scholar
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: A global feasibility study.
O. Akkerman, A. Aleksa, J. Alffenaar, Nada Almarzouqi +76 more
2019International Journal of Infectious Diseases52 citations Open access
Semantic Scholar
Clinical standards for the management of adverse effects during treatment for TB
K. P. Singh, A. Carvalho, R. Centis, L. D. Ambrosio +61 more
2023The International Journal of Tuberculosis and Lung Disease49 citations Open access
Semantic Scholar
Outcome of treatment of MDR-TB or drug-resistant patients treated with bedaquiline and delamanid: Results from a large global cohort.
S. Koirala, S. Borisov, E. Danila, A. Mariandyshev +94 more
2021Pulmonology48 citations Open access
Semantic Scholar
Serum Biomarker Profile Including CCL1, CXCL10, VEGF, and Adenosine Deaminase Activity Distinguishes Active From Remotely Acquired Latent Tuberculosis
E. Delemarre, Laura van Hoorn, A. Bossink, J. Drylewicz +14 more
2021Frontiers in Immunology40 citations Open access
Semantic Scholar
Rehabilitation, optimized nutritional care and boosting host internal milieu to improve long-term treatment outcomes in TB patients.
O. Akkerman, L. ter Beek, R. Centis, M. Maeurer +4 more
2020International Journal of Infectious Diseases37 citations Open access
Semantic Scholar
The effect of COVID-19 on transplant function and development of CLAD in lung transplant patients: A multicenter experience
E. Roosma, J. V. van Gemert, A. D. de Zwart, C. V. van Leer-Buter +9 more
2022The Journal of Heart and Lung Transplantation36 citations Open access
Semantic Scholar
Sensitivity and specificity of an electronic nose in diagnosing pulmonary tuberculosis among patients with suspected tuberculosis
Antonia M. I. Saktiawati, Y. Stienstra, Y. Subronto, N. Rintiswati +5 more
2019PLoS ONE35 citations Open access
Semantic Scholar
Pulmonary tuberculosis in intensive care setting, with a focus on the use of severity scores, a multinational collaborative systematic review
J. Galvin, Simon Tiberi, O. Akkerman, H. Kerstjens +4 more
2022Pulmonology33 citations Open access
Semantic Scholar
Long-term outcomes of the global tuberculosis and COVID-19 co-infection cohort
Nicolas Casco, Alberto Jorge, D. Palmero, Jan-Willem C. Alffenaar +174 more
2023European Respiratory Journal31 citations Open access
Semantic Scholar
Treatment outcomes of drug-resistant tuberculosis in the Netherlands, 2005–2015
I. S. Pradipta, N. Van't Boveneind-Vrubleuskaya, O. Akkerman, J. Alffenaar +1 more
2019Antimicrobial Resistance and Infection Control30 citations Open access
Semantic Scholar
Tuberculosis-Related Malnutrition: Public Health Implications.
L. ter Beek, J. Alffenaar, M. Bolhuis, T. V. van der Werf +1 more
2019Journal of Infectious Diseases29 citations Open access
Semantic Scholar
Post-tuberculosis treatment paradoxical reactions
S. Hermans, O. Akkerman, Graeme Meintjes, M. Grobusch
2024Infection28 citations Open access
Semantic Scholar
Evaluation of whole-genome sequence data analysis approaches for short- and long-read sequencing of Mycobacterium tuberculosis
Nilay Peker, L. Schuele, Nienke Kok, Miguel A. Terrazos +10 more
2021Microbial Genomics25 citations Open access
Semantic Scholar
Precision and Personalized Medicine and anti-TB treatment: Is TDM feasible for programmatic use?
J. Alffenaar, O. Akkerman, H. Kim, Simon Tiberi +1 more
2020International Journal of Infectious Diseases25 citations Open access
Semantic Scholar
Diagnostic accuracy of chest X-ray interpretation for tuberculosis by three artificial intelligence-based software in a screening use-case: an individual patient meta-analysis of global data
S. Kik, S. Gelaw, M. Ruhwald, R. Song +20 more
2022medRxiv24 citations Open access
Semantic Scholar
Predictors for treatment outcomes among patients with drug-susceptible tuberculosis in the Netherlands: a retrospective cohort study.
I. S. Pradipta, N. Van't Boveneind-Vrubleuskaya, O. Akkerman, J. Alffenaar +1 more
2019Clinical Microbiology and Infection24 citations Open access
Semantic Scholar
Practices of therapeutic drug monitoring in tuberculosis: an international survey
I. Margineanu, O. Akkerman, D. Cattaneo, D. Goletti +6 more
2022European Respiratory Journal22 citations Open access
Semantic Scholar
Malnutrition assessment methods in adult patients with tuberculosis: a systematic review
L. ter Beek, M. Bolhuis, H. Jager-Wittenaar, R. Brijan +7 more
2021BMJ Open22 citations Open access
Semantic Scholar
Imaging in pulmonary infections of immunocompetent adult patients
S. Pochepnia, E. Grabczak, Emma Johnson, F. O. Eyuboglu +2 more
2024Breathe21 citations Open access
Semantic Scholar
Population Pharmacokinetic Modelling and Limited Sampling Strategies for Therapeutic Drug Monitoring of Pyrazinamide in Patients with Tuberculosis
Reihaneh Abolhassani-Chimeh, O. Akkerman, A. Saktiawati, N. Punt +7 more
2022Antimicrobial Agents and Chemotherapy21 citations Open access
Semantic Scholar
Nationwide analysis of treatment outcomes in children and adolescents routinely treated for tuberculosis in the Netherlands
F. Gafar, N. Van't Boveneind-Vrubleuskaya, O. Akkerman, B. Wilffert +1 more
2019European Respiratory Journal21 citations Open access
Semantic Scholar
Safety and Outcomes of Amikacin Liposome Inhalation Suspension for Mycobacterium abscessus Pulmonary Disease
Maria Henriette Zweijpfenning Sanne, R. Chiron, S. Essink, J. Schildkraut +14 more
2022Chest19 citations Open access
Semantic Scholar
Therapeutic drug monitoring using saliva as matrix: an opportunity for linezolid, but challenge for moxifloxacin
Simone H. J. van den Elsen, O. Akkerman, E. M. Jongedijk, M. Wessels +5 more
2020European Respiratory Journal19 citations Open access
Semantic Scholar
Performance of a web-based application measuring spot quality in dried blood spot sampling
Herman Veenhof, R. Koster, Randy Brinkman, Enes Senturk +5 more
2019Clinical Chemistry and Laboratory Medicine18 citations Open access
Semantic Scholar
Clinical standards for drug-susceptible pulmonary TB
O. Akkerman, R. Duarte, Simon Tiberi, H. S. Schaaf +43 more
2022The International Journal of Tuberculosis and Lung Disease17 citations Open access
Semantic Scholar
Tuberculosis patients
C. Magis-Escurra, Simon Tiberi, O. Akkerman, Raquel Duarte
2021Supporting Tobacco Cessation17 citations
Semantic Scholar
Rapid Diagnosis of XDR and Pre-XDR TB: A Systematic Review of Available Tools.
L. Saderi, M. Puci, B. Di Lorenzo, R. Centis +15 more
2022Archivos de Bronconeumologia16 citations Open access
Semantic Scholar
eHealth in TB clinical management
I. Margineanu, C. Louka, O. Akkerman, Y. Stienstra +1 more
2022The International Journal of Tuberculosis and Lung Disease15 citations Open access
Semantic Scholar
Should we worry about bedaquiline exposure in the treatment of multidrug-resistant and extensively drug-resistant tuberculosis?
J. Alffenaar, O. Akkerman, Simon Tiberi, G. Sotgiu +1 more
2019European Respiratory Journal15 citations Open access
Semantic Scholar
Colistin dry powder inhalation with the Twincer™: An effective and more patient friendly alternative to nebulization
A. M. Akkerman-Nijland, F. Grasmeijer, H. Kerstjens, H. Frijlink +6 more
2020PLoS ONE14 citations Open access
Semantic Scholar
Eradication of Pseudomonas aeruginosa in cystic fibrosis patients with inhalation of dry powder tobramycin
A. M. Akkerman-Nijland, M. Yousofi, B. Rottier, H. van der Vaart +5 more
2020Therapeutic Advances in Respiratory Disease14 citations Open access
Semantic Scholar
The agreement between bronchoalveolar lavage, bronchial wash and sputum culture: a retrospective study
Anne-Eva Post, E. Bathoorn, D. Postma, D. Slebos +1 more
2024Infection13 citations Open access
Semantic Scholar
Model-Informed Precision Dosing of Linezolid in Patients with Drug-Resistant Tuberculosis
Laurynas Mockeliunas, Lina Keutzer, M. Sturkenboom, M. Bolhuis +3 more
2022Pharmaceutics13 citations Open access
Semantic Scholar
Pharmacokinetics of Ivacaftor, Tezacaftor, Elexacaftor, and Lumacaftor in Special Cystic Fibrosis Populations: A Systematic Review
F. Elzinga, Paul Malik, O. Akkerman, B. L. Rottier +4 more
2025Clinical Pharmacokinetics10 citations Open access
Semantic Scholar
Identification of circulating monocytes as producers of tuberculosis disease biomarker C1q
P. Niewold, D. Dijkstra, Yi Cai, D. Goletti +13 more
2023Scientific Reports10 citations Open access
Semantic Scholar
Prospective evaluation of improving fluoroquinolone exposure using centralised therapeutic drug monitoring (TDM) in patients with tuberculosis (PERFECT): a study protocol of a prospective multicentre cohort study
Simone H. J. van den Elsen, M. Sturkenboom, O. Akkerman, Linda Barkāne +22 more
2020BMJ Open10 citations Open access
Semantic Scholar
Dose optimisation of first-line tuberculosis drugs using therapeutic drug monitoring in saliva: feasible for rifampicin, not for isoniazid
Simone H. J. van den Elsen, O. Akkerman, M. Wessels, E. M. Jongedijk +5 more
2020European Respiratory Journal10 citations Open access
Semantic Scholar
Non-tuberculous mycobacteria disease pre-lung transplantation: A systematic review of the treatment regimens and duration pre- and post-transplant.
J. V. van Gemert, S. Ravensbergen, E. Verschuuren, H. Kerstjens +5 more
2023Transplantation reviews9 citations Open access
Semantic Scholar
Combining digital adherence technology and therapeutic drug monitoring for personalised tuberculosis care
S. Ghimire, Deni Iskandar, Roelina van der Borg-Boekhout, M. Zenina +7 more
2022European Respiratory Journal9 citations Open access
Semantic Scholar
Clinical Relevance of Rifampicin‐Moxifloxacin Interaction in Isoniazid-Resistant/Intolerant Tuberculosis Patients
Vanessa B. Vogensen, M. Bolhuis, M. Sturkenboom, T. V. van der Werf +6 more
2021Antimicrobial Agents and Chemotherapy9 citations Open access
Semantic Scholar
Corticosteroid therapy for the management of paradoxical inflammatory reaction in patients with pulmonary tuberculosis
Macky M. Done, O. Akkerman, Wud Al-Kailany, W. de Lange +4 more
2020Infection9 citations Open access
Semantic Scholar
Isoniazid and rifampicin exposure during treatment in drug-susceptible TB.
O. Akkerman, R. D. C. Dijkwel, H. Kerstjens, T. V. van der Werf +3 more
2023The International Journal of Tuberculosis and Lung Disease8 citations Open access
Semantic Scholar
Country-specific approaches to latent tuberculosis screening targeting migrants in EU/EEA* countries: A survey of national experts, September 2019 to February 2020
I. Margineanu, K. Rustage, T. Noori, Dominik Zenner +8 more
2022Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin8 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

Simon Tiberi×16
Invite
Simon Tiberi — researcher profile on SciRah
M. Bolhuis×12
Invite
M. Bolhuis — researcher profile on SciRah
G. Migliori×12
Invite
G. Migliori — researcher profile on SciRah
J. Alffenaar×12
Invite
J. Alffenaar — researcher profile on SciRah

T. V. van der Werf

×11

Invite

T. V. van der Werf — researcher profile on SciRah

Invite

R. Centis — researcher profile on SciRah

Invite

M. Tadolini — researcher profile on SciRah

Invite

G. Sotgiu — researcher profile on SciRah

Invite

D. Touw — researcher profile on SciRah

M. Sturkenboom×8

Invite

M. Sturkenboom — researcher profile on SciRah

Invite

D. Palmero — researcher profile on SciRah

J. Alffenaar×7

Invite

J. Alffenaar — researcher profile on SciRah